Canine Health Foundation

CHF

The CHF Hemangiosarcoma Challenge

CHF launched new matched funding initiatives for 2018, thanks to the generosity of the AKC. First, all donations and/or Donor Advised Fund transfers in 2018 for hemangiosarcoma research will be matched up to $250K. We are proud to say GRF is the first to pledge $100,000! CHF has a separate match for any Donor Advised Fund transfers to the research area of the donor’s choice up to $250K.

From the GRCA Research Facilitator

The Golden Retriever Foundation is pleased to provide this portfolio of scientific papers generated by its nearly 20 years of research funding through the AKC Canine Health Foundation (CHF). We are grateful to CHF for the tremendous amount of work they did in compiling this review, and for their expert guidance in selection and administration of the projects.

These papers have been published in peer-reviewed journals, which mean that they have undergone scrutiny for merit and accuracy by other scientists working in the field. An abstract (summary) of the research findings can be accessed by searching the title of the paper at www.pubmed.gov, and in some cases the full paper is also available. Although these abstracts are typically very technical, frequently the “Conclusion” or final sentences can be useful to general readers.

The success and impact of research is often measured by the peer-reviewed papers that result, and we are very proud to share this impressive compilation with GRF supporters who made it possible, and all Golden owners.

CHF Grant Sponsorships and Resulting Publications through 2017

For assistance with any of these papers, contact rhondahovan@aol.com

AKC Canine Health Foundation

AKC Canine Health Foundation (CHF) has been busy this past year. Their programs expenditures for canine health research in 2017 was over $1.93 million awarded for new research grants. Their grants portfolio is on the CHF website: http://www.akcchf.org/research/our-research/
They have headed into 2018 with more than $600K in new grants already awarded just in the area of canine cancer research alone: hemangiosarcoma, mammary gland cancer, lymphoma, bladder cancer and cutting edge approaches to new therapeutics including checkpoint inhibitors and immunotherapy.

Also funded are new research into canine vaccines for brucellosis and coccidioidomycosis (a devastating fungal disease in the SW US), and infectious disease research for Chagas Disease and CHF’s ongoing commitment to tick-borne disease research. They have a new section on their website addressing infectious diseases, which contains updated informational pdfs that can be downloaded and shared: http://www.akcchf.org/canine-health/top-health-concerns/top-health-concerns.html